Araştırma Makalesi

Antiproliferative Activity of Pyrrolidine Derivatives compound in Colon Cancer Cells

Cilt: 4 Sayı: 1 27 Şubat 2022
PDF İndir
TR EN

Antiproliferative Activity of Pyrrolidine Derivatives compound in Colon Cancer Cells

Öz

Objective: Anti-cancer drug research plays an important role for chemotherapeutic treatments in various types of cancer. Pyrolidine derived compounds have been reported by many researchers to be a potent anti-cancer compound. It is aimed to investigate the effects of pyrolidine-derived compounds that are thought to be new drug candidates with antiproliferative activity on DLD-1 and CCD-18CO cell lines.

Material and Methods: The antiproliferative activity of the pyrrolidine-derived compound was determined for 24 hours at different concentrations (25-100 µM) on DLD-1 (human colon cancer) and CCD-18CO (normal colon fibroblast) cell lines by comparing MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5 Diphenyltetrazolium bromide) and RTCA (real-time cell analysis) assays. The significance of the differences between data sets in the MTT assay was analyzed statistically by ANOVA with SPSS 20.0 program for DLD-1 and CCD-18CO cell lines.

Results: It has been determined that pyrrolidine-derived compounds reduce the number of DLD-1 cancer cells according to negative control with the MTT method and suppress the DLD-1 cell according to the RTCA assay results. Thus, the compounds have been shown to inhibit cell proliferation and have antiproliferative activity.

Conclusion: Pyrrolidine-derived compounds will be the first step for antiproliferative activity studies in DLD-1 cancer cells and will guide the next studies.

Anahtar Kelimeler

Destekleyen Kurum

Amasya Üniversitesi

Proje Numarası

FMB-BAP 18-0333

Teşekkür

The authors would like to thank Hela Aguerbi (Hitit University) for the critical reading of the manuscript.

Kaynakça

  1. 1. Haggar FA, Boushey RP. Colorectal cancer epidemiology: incidence, mortality, survival, and risk factors. Clin Colon Rectal Surg 2009;22:191-197.
  2. 2. Kuipers EJ, Rösch T, Bretthauer M. Colorectal cancer screening-optimizing current strategies and new directions. Nat Rev Clin Oncol 2013;10:130-142.
  3. 3. Talib WH, Mahasneh AM. Antiproliferative activity of plant extracts used against cancer in traditional medicine. Sci Pharm 2010;78:33-45.
  4. 4. Kuipers EJ, Grady WM, Lieberman D et al. Colorectal cancer. Nat Rev Dis Primers 2015;1:15065.
  5. 5. Zięba A, Latocha M, Sochanik A, Nycz, A, Kuśmierz D, Synthesis and in vitro Antiproliferative Activity of Novel henyl RingSubstituted 5-Alkyl-12(H)-quino[3,4-b][1,4]benzothiazine Derivatives. Molecules (Basel, Switzerland) 2016;21:1455.
  6. 6. Hati S, Tripathy S, Dutta PK et al. Spiro[pyrrolidine-3, 3-oxindole] as potent anti-breast cancer compounds: Their design, synthesis, biological evaluation and cellular target identification. Sci Rep 2016;6,32213.
  7. 7. Tahata S, Yuan B, Kikuchi H, Takagi N, Hirano T, Toyoda H. Cytotoxic effects of pyrrolidine dithiocarbamate in small-cell lung cancer cells, alone and in combination with cisplatin. Int J Oncol 2014;45:1749-1759.
  8. 8. Huang Y, Huang YX, Sun J, Yan CG. A [3+2] cycloaddition reaction for the synthesis of spiro[indoline-3,3′-pyrrolidines] and evaluation of cytotoxicity towards cancer cells. New Journal of Chemistry 2019;43:8903-8910.

Ayrıntılar

Birincil Dil

İngilizce

Konular

Klinik Tıp Bilimleri

Bölüm

Araştırma Makalesi

Yayımlanma Tarihi

27 Şubat 2022

Gönderilme Tarihi

21 Nisan 2021

Kabul Tarihi

28 Ekim 2021

Yayımlandığı Sayı

Yıl 2022 Cilt: 4 Sayı: 1

Kaynak Göster

APA
Mesci, S., Gül, M., & Yıldırım, T. (2022). Antiproliferative Activity of Pyrrolidine Derivatives compound in Colon Cancer Cells. Hitit Medical Journal, 4(1), 1-5. https://doi.org/10.52827/hititmedj.924278
AMA
1.Mesci S, Gül M, Yıldırım T. Antiproliferative Activity of Pyrrolidine Derivatives compound in Colon Cancer Cells. Hitit Medical Journal. 2022;4(1):1-5. doi:10.52827/hititmedj.924278
Chicago
Mesci, Seda, Melek Gül, ve Tuba Yıldırım. 2022. “Antiproliferative Activity of Pyrrolidine Derivatives compound in Colon Cancer Cells”. Hitit Medical Journal 4 (1): 1-5. https://doi.org/10.52827/hititmedj.924278.
EndNote
Mesci S, Gül M, Yıldırım T (01 Şubat 2022) Antiproliferative Activity of Pyrrolidine Derivatives compound in Colon Cancer Cells. Hitit Medical Journal 4 1 1–5.
IEEE
[1]S. Mesci, M. Gül, ve T. Yıldırım, “Antiproliferative Activity of Pyrrolidine Derivatives compound in Colon Cancer Cells”, Hitit Medical Journal, c. 4, sy 1, ss. 1–5, Şub. 2022, doi: 10.52827/hititmedj.924278.
ISNAD
Mesci, Seda - Gül, Melek - Yıldırım, Tuba. “Antiproliferative Activity of Pyrrolidine Derivatives compound in Colon Cancer Cells”. Hitit Medical Journal 4/1 (01 Şubat 2022): 1-5. https://doi.org/10.52827/hititmedj.924278.
JAMA
1.Mesci S, Gül M, Yıldırım T. Antiproliferative Activity of Pyrrolidine Derivatives compound in Colon Cancer Cells. Hitit Medical Journal. 2022;4:1–5.
MLA
Mesci, Seda, vd. “Antiproliferative Activity of Pyrrolidine Derivatives compound in Colon Cancer Cells”. Hitit Medical Journal, c. 4, sy 1, Şubat 2022, ss. 1-5, doi:10.52827/hititmedj.924278.
Vancouver
1.Seda Mesci, Melek Gül, Tuba Yıldırım. Antiproliferative Activity of Pyrrolidine Derivatives compound in Colon Cancer Cells. Hitit Medical Journal. 01 Şubat 2022;4(1):1-5. doi:10.52827/hititmedj.924278